Metaplastic BC is a rare and heterogenous subtype associated with poor prognosis overall18 and poor response to cytotoxic chemotherapy19,20 but in which preliminary data suggest the possibility of responsiveness to immunotherapy with frequent PD-L1 expression21 and a subset of patients with exceptional responses to combined checkpoint blockade on a phase 2 trial22. Here, CD274 is linked to breast cancer.